GlassScriptPhysician profile
Leann R Holmes
NPI 1083620207
$1,784.40
in general payments reported to CMS, 2019-2025
18 companies · $341 in 2025
The $341 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $339 · 2022: $512 · 2023: $238 · 2024: $355 · 2025: $341.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $933.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $933.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $450.37 | 2021-2025 | |
| Novo Nordisk INC | $326.63 | 2021-2025 | Ozempic, Wegovy |
| Astrazeneca Pharmaceuticals LP | $249.13 | 2023-2024 | Farxiga |
| Gilead Sciences, INC. | $149.66 | 2024 | Descovy |
| Biohaven Pharmaceutical Holding Company LTD. | $111.04 | 2022 | |
| Optinose US, INC. | $92.48 | 2021 | |
| Coloplast Corp | $82.44 | 2023 | Titan |
| Bayer Healthcare Pharmaceuticals INC. | $76.24 | 2022 | |
| Pfizer INC. | $44.44 | 2024-2025 | |
| Mylan Specialty L.P. | $44.29 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $32.97 | 2022-2024 | Xifaxan |
| Upsher-Smith Laboratories LLC | $22.03 | 2021 | |
| Viiv Healthcare Company | $21.69 | 2022 | |
| Merck Sharp & Dohme LLC | $19.19 | 2021 | |
| Amgen INC. | $17.84 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vanda Pharmaceuticals INC. | $16.25 | 2025 | Fanapt |
| Axsome Therapeutics, INC. | $16.03 | 2025 | Auvelity |
| Neos Therapeutics, LP | $11.68 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leann Holmes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.